Singapore markets closed

bioAffinity Technologies, Inc. (BIAF)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.0200-0.0500 (-2.42%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 23.83M
Enterprise value 22.59M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.15
Price/book (mrq)4.91
Enterprise value/revenue 8.92
Enterprise value/EBITDA -2.96

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 39.19%
S&P500 52-week change 326.43%
52-week high 33.6200
52-week low 30.9550
50-day moving average 32.2735
200-day moving average 31.7261

Share statistics

Avg vol (3-month) 3246.07k
Avg vol (10-day) 392.97k
Shares outstanding 511.51M
Implied shares outstanding 611.8M
Float 87.57M
% held by insiders 135.04%
% held by institutions 11.36%
Shares short (15 Apr 2024) 4240.87k
Short ratio (15 Apr 2024) 41.26
Short % of float (15 Apr 2024) 44.04%
Short % of shares outstanding (15 Apr 2024) 42.09%
Shares short (prior month 15 Mar 2024) 462.71k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-105.83%

Management effectiveness

Return on assets (ttm)-48.85%
Return on equity (ttm)-99.85%

Income statement

Revenue (ttm)2.53M
Revenue per share (ttm)0.29
Quarterly revenue growth (yoy)94,246.00%
Gross profit (ttm)N/A
EBITDA -7.6M
Net income avi to common (ttm)-7.94M
Diluted EPS (ttm)-0.9100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.82M
Total cash per share (mrq)0.25
Total debt (mrq)1.58M
Total debt/equity (mrq)32.51%
Current ratio (mrq)1.77
Book value per share (mrq)0.52

Cash flow statement

Operating cash flow (ttm)-6.04M
Levered free cash flow (ttm)-3.61M